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Dengue fever (DF) and dengue hemorrhagic
fever (DHF) are caused by infection with one of
the four serotypes of dengue virus (DEN-1,
DEN-2, DEN-3, and DEN-4), transmitted by
Aedes aegypti mosquitoes. In Brazil, DF
epidemics reported in the 1980s and 1990s involved
more than a million cases. However, only 671
DHF cases were diagnosed, with 26 deaths (1).
Ae. aegypti was reintroduced in Pará State in
1992, and the first dengue cases were reported in
1995 in the southeast region (Redenção and
Rondon do Pará). In October 1996, eight cases of
febrile denguelike illness were reported in Belém
(population 1,300,000), a city in the Brazilian
Amazon region at the confluence of the Amazon
River and the Atlantic Ocean. In early November,
DEN-1 virus was isolated and identified (2-4).
DEN-2 virus was identified in October 1997, and
since then, both serotypes have been responsible
for illness in Belém. This was the first time
dengue virus transmission occurred in Belém
during the last 70 years and the third time the
disease occurred in the Brazilian Amazon region.
Previous outbreaks had been reported in 1981-82
in Boa Vista, Roraima (5), and in 1991 in
Araguaina, Tocantins State (6).
We describe cases of denguelike illness
diagnosed at Instituto Evandro Chagas. A case of
dengue was defined as illness with the following
symptoms: acute onset of high fever, headache,
myalgia, arthralgia, dizziness, and other symp-
toms and signs suggestive of denguelike illness in
a patient with a positive IgM by IgM-capture
enzyme-linked immunosorbent assay (MAC
ELISA), virus isolation or serologic conversion in
paired serum samples, and an increase of at least
fourfold in titer in the convalescent-phase serum
sample (7-9).
The Study
From January to December 1997, 40,237
serum samples were drawn from febrile patients
in Belém, 20,038 (49.8%) of whom were male. The
patients were all residents of the municipalities
of Belém (31,506 samples) and Ananindeua
(8,731 samples). Most were ambulatory patients
seen in the Arbovirus Department, Evandro
Chagas Institute; some patients were referred by
public health centers, private physicians, and
clinics. At the Institute, all patients were
examined clinically and had blood samples
drawn. A questionnaire was administered that
included information about clinical symptoms
and signs and demographic data. Patients who
had been ill <10 days and whose serologic tests
were negative for dengue were requested to
provide a second blood sample 7 to 14 days later.
For patients who had at least one hemorrhage
and either dehydration or hemoconcentration, a
leukogram, platelet count, and hematocrit were
performed.
Serum samples were tested for dengue
antibodies by MAC ELISA (4) and hemagglutina-
tion-inhibition test (2). The antigens for both
tests were prepared by using infected mouse
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were positive for dengue by virus isolation or serologic testing. No hemorrhagic cases
or deaths were reported.
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Figure. Monthly distribution of rain precipitation
(line) and dengue fever cases as seen at Instituto
Evandro Chagas, Pará, Brazil. Source for rain
precipitation, Instituto Nacional de Meteorologia,
Brazil.
Table 1. Distribution of patients with  serologic tests positive for dengue
Male Female Total
Age No. Pos % No. Pos % Pos %
<4      186      60     0.76      325      76     0.8      136     0.78
5–9      308      89     1.12      425    186     1.96      275     1.58
10–14   1,033    444     5.56      816    356     3.76      800     4.59
15–24   4,080 1,596   20   3,765 1,643   17.35   3,239   18.56
25–34   5,083 2,184   27.37   4,375 2,127   22.47   4,311   24.7
35–44   3,919 1,684   21.1   4,638 2,023   21.37   3,707   21.25
45–54   3,319 1,016   12.73   3,572 1,558   16.46   2,574   14.75
>55   2,110    898   11.36   2,283 1,500   15.83   2,398   13.79
Total 20,038 7,971 100 20,199 9,469 100 17,440 100
brain extracted by the sucrose acetone method.
The criteria used for establishing primary and
secondary infection were those recommended by
the World Health Organization (7,8).
To isolate dengue virus, 0.1-ml aliquots of
whole blood from patients with clinical
symptoms lasting <5 days and negative
serologic results were injected into cultures of
C6/36 cells (10). The cultures were visually
examined daily, and cells were tested on days 7
and 14 by immunofluorescence (3).
Isolated virus strains were initially screened
by direct immunofluorescence against a flavivirus
standard hyperimmune fluid prepared at the
Institute. Strains that reacted were identified to
serotype by using an indirect immunofluores-
cence test with monoclonal antibodies against the
four dengue viruses provided by the Centers for
Disease Control and Prevention.
The epidemic distribution was accompanied
early in 1997 by a seasonal increase in rainfall
typical of the Brazilian Amazon. However, the
highest dengue positivity rates were reported in
the dry months of September to December.
Coincidentally, DEN-2 virus was isolated in
October. At first, cases were reported only in Belém
and Ananindeua, but in December 1997, at least 15
other municipalities reported transmission
cycles involving either DEN-1 or DEN-2 or both.
Of all sera collected, 17,525 (43.5%) were
positive by serologic testing or DEN virus
isolation: 13,805 (78.8%) from Belém and 3,720
(21.2%) cases from Ananindeua (Figure). Both
primary and secondary serologic responses were
found. Among the positive samples, 9,469
(54.25%) were among female and 7,971 (45.75%)
among male patients (p < 0.0001); 45.95% of the
patients were 25 to 44 years of age (Table 1).
Paired serum samples were obtained from 3,558
patients, 2,997 (84.2%) of whom had serologic
conversions.
No DHF cases were reported, in spite of the
fact that since October 1997 DEN-2 had been
isolated from 24 patients with previous DEN-1
infection (Table 2). Clinical symptoms were more
severe in older children and adults than in young
children, but no differences were observed
between the clinical symptoms of patients with
DEN-1 and DEN-2 infection.Dispatches Dispatches Dispatches Dispatches Dispatches
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Table 2. Strains of dengue virus isolated from patients
from Belém and Ananindeua, Instituto Evandro Chagas,
October 1996 to August 1998
DEN-1 DEN-2 Total
1996   31    -   31
1997 751   48 799
1998a   58   60 118
Total 840 108 948
aThrough August.
Conclusions
During 1953 and 1954, Causey and Theiler (11)
used seroneutralization in mice to survey several
municipalities of the Amazon region; they found
9.8% and 2.2% of serum samples positive for
dengue virus serotypes DEN-1 and DEN-2,
respectively, among residents  > 50 years of age.
These results suggest that dengue viruses were
circulating in Belém and other municipalities of
the Amazon Valley early in the 20th century.
The dengue epidemic in Belém was unusual
in that a “lag phase” (12) lasted for at least 4
months before extensive transmission began. In
spite of laboratory diagnosis of cases from the
beginning of the outbreak and the reporting of
these results to health authorities, control
measures were unsuccessful. Consequently,
explosive transmission began in March 1997 and
is still occurring (1998-99).
In the last 4 years, the Brazilian Ministry of
Health (13) has reported an increase in dengue
cases from approximately 56,000 in 1994 to
>530,000 in 1998. High indexes of Ae. aegypti
infestation exist in all important urban centers of
Brazil, reflecting a poor health education
program. The fact that more cases occurred in
female than in male patients (p <0.0001) suggests
that women are at increased risk for dengue
infection because of high peridomestic exposure.
Dengue transmission has been reported in 22
of the 27 Brazilian states, and the mosquito
vector is present in all states; therefore, the
situation in Brazil may be rapidly approaching
hyperendemicity, with the cocirculation of two
serotypes (DEN-1 since 1986 and DEN-2 since
1990). The risk for DHF will increase if a new
serotype (DEN-3 or DEN-4) is introduced.
Endemicity is the most constant factor associated
with the evolution of epidemic DHF in a
geographic area (14). Although few cases have
been reported until recently, DHF may become
an important cause of hospitalization and death
in the Americas, including Brazil.
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